Alexion Pharmaceuticals

An Orbimed-backed biotech launches with $85M and plans for a new kind of DNA medicine
BioPharma Dive
Tue, 10/24/23 - 09:59 am
Rampart Biosciences
OrbiMed
Alexion Pharmaceuticals
Strensiq
hypophosphatasia
Alexion Ends Rare Kidney Disease Program Following Poor Data
BioSpace
Fri, 07/31/20 - 11:06 pm
Alexion Pharmaceuticals
Achillion
M&A
kidney disease
Alexion Pharmaceuticals Agrees to $21.5 Million Settlement With SEC in Bribery Case
Motley Fool
Mon, 07/6/20 - 10:29 am
Alexion Pharmaceuticals
SEC
bribery
FCPA
Apellis' blood disorder drug outdoes Alexion's Soliris in improving hemoglobin levels
Reuters
Tue, 01/7/20 - 10:55 am
Apellis Pharmaceuticals
Alexion Pharmaceuticals
PNH
pegcetacoplan
Soliris
Alexion Rises After Drug Developer Beats Earnings Expectations
TheStreet.com
Wed, 10/23/19 - 09:36 am
Alexion Pharmaceuticals
earnings
Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms
Xconomy
Wed, 10/16/19 - 12:48 pm
Alexion Pharmaceuticals
Achillion
M&A
PNH
danicopan
Soliris
Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report
Investors Business Daily
Thu, 08/22/19 - 05:07 pm
Amgen
Alexion Pharmaceuticals
M&A
Alexion reports positive phase 3 extension data for ULTOMIRIS in paroxysmal nocturnal hemoglobinuria
Pharmaceutical Business Review
Mon, 06/17/19 - 10:03 am
Alexion Pharmaceuticals
Ultomiris
PNH
4 Blockbuster Drug Launches to Watch in 2019
Motley Fool
Sun, 03/24/19 - 08:08 pm
drug launches
AbbVie
Alexion Pharmaceuticals
Aimmune Therapeutics
Skyrizi
psoriasis
Upadacitinib
rheumatoid arthritis
Ultomiris
PNH
AR101
peanut allergy
Alexion adds to pipeline with two early-stage R&D deals
BioPharma Dive
Wed, 03/20/19 - 12:25 pm
Alexion Pharmaceuticals
Affibody
Zealand Pharma
ABY-039
R&D
Alexion aims for fourth rare disease use for blockbuster Soliris
Pharmaforum
Tue, 02/26/19 - 09:36 am
Alexion Pharmaceuticals
Soliris
neuromyelitis optica spectrum disorder
Alexion Strikes Development Deal With Caelum Biosciences in Rare Systemic Disorder
BioSpace
Thu, 01/31/19 - 11:18 am
Alexion Pharmaceuticals
Fortress Biotech
Caelum Biosciences
CAEL-101
light chain amyloidosis
Alexion’s newly approved rare-disease drug notches another clinical trial win
Stat
Mon, 01/28/19 - 11:10 am
Alexion Pharmaceuticals
clinical trials
Ultomiris
kidney disease
PNH
Alexion wins approval for rare disease drug, aims to switch patients from blockbuster Soliris
Stat
Fri, 12/21/18 - 11:51 am
Alexion Pharmaceuticals
FDA
Ultomiris
Soliris
PNH
Alexion Pharmaceuticals acquires Boston-based biotech company
New Haven Register
Sun, 11/4/18 - 02:31 pm
Alexion Pharmaceuticals
M&A
Syntimmune
Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/20/18 - 11:16 pm
earnings
biotech
Biogen
Alexion Pharmaceuticals
Bristol-Myers Squibb
Celgene
Gilead Sciences
Merck
Biomarin
Galapagos
Seattle Genetics
Dr Reddy's
3 Biotech Stocks With Virtual Monopolies
Motley Fool
Wed, 10/3/18 - 11:53 am
Alexion Pharmaceuticals
Biomarin
Vertex Pharmaceuticals
FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria
CP Wire
Mon, 08/20/18 - 11:40 am
Alexion Pharmaceuticals
Alexion
FDA
ALXN210
PNH
paroxysmal nocturnal hemoglobinuria
FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria
Mon, 08/20/18 - 09:59 am
Alexion Pharmaceuticals
paroxysmal nocturnal hemoglobinuria
ALXN1210
Alexion Being Probed by HHS Inspector General; Shares Fall
Bloomberg
Thu, 07/6/17 - 06:08 pm
Alexion Pharmaceuticals
HHS
Soliris
fraud

Pages